Search results for "G2"
showing 10 items of 439 documents
"Figure 5a" of "Measurement of jet-medium interactions via direct photon-hadron correlations in Au$+$Au and $d$$+$Au collisions at $\sqrt{s_{_{NN}}}=…
2021
$I_{AA}$ vs $\xi$ for direct photon $p_{T}^{\gamma}$ of 5-7 GeV/$c$, 7-9 GeV/$c$, and 9-12 GeV/$c$.
"Figure 3" of "Measurement of jet-medium interactions via direct photon-hadron correlations in Au$+$Au and $d$$+$Au collisions at $\sqrt{s_{_{NN}}}=2…
2021
Per-trigger yield of hadrons associated to direct photons in d+Au collisions for direct photon $p_T$ 7-9 GeV/$c$, compared with p+p baseline, in various $\xi$ bins.
"Figure 4a" of "Measurement of jet-medium interactions via direct photon-hadron correlations in Au$+$Au and $d$$+$Au collisions at $\sqrt{s_{_{NN}}}=…
2021
Integrated away-side $\gamma_{dir}$-h per-trigger $I_{AA}$ and $I_{dA}$ of Au+Au, d+Au, and p+p, as a function of $\xi$.
"Figure 7" of "Measurement of jet-medium interactions via direct photon-hadron correlations in Au$+$Au and $d$$+$Au collisions at $\sqrt{s_{_{NN}}}=2…
2021
Ratios of $I_{AA}$ as a function of direct photon $p_T$ for three different away-side integration ranges.
"Figure 6c" of "Measurement of jet-medium interactions via direct photon-hadron correlations in Au$+$Au and $d$$+$Au collisions at $\sqrt{s_{_{NN}}}=…
2021
$I_{AA}$ as a function of $\xi$ for direct photon $p_{T}^{\gamma}$ of 5-7, 7-9, and 9-12 GeV/$c$. Three away-side integration ranges are chosen to calculate the per-trigger yield and the corresponding $I_{AA}$, $|\Delta\phi-\pi|<\pi/2$, $|\Delta\phi-\pi|<\pi/3$, and $|\Delta\phi-\pi|<\pi/6$.
"Figure 8c" of "Measurement of jet-medium interactions via direct photon-hadron correlations in Au$+$Au and $d$$+$Au collisions at $\sqrt{s_{_{NN}}}=…
2021
Measured $I_{AA}$ for direct photon $p_T$ of 5-7, 7-9, and 9-12 GeV/$c$, as a function of $\xi$, are compared with theoretical model calculations.
Enhancing the Activation and Releasing the Brakes: A Double Hit Strategy to Improve NK Cell Cytotoxicity Against Multiple Myeloma
2018
Natural killer (NK) cells are innate lymphocytes with a strong antitumor ability. In tumor patients, such as multiple myeloma (MM) patients, an elevated number of NK cells after stem cell transplantation (SCT) has been reported to be correlated with a higher overall survival rate. With the aim of improving NK cell use for adoptive cell therapy, we also addressed the cytotoxicity of patient-derived, cytokine-stimulated NK cells against MM cells at specific time points: at diagnosis and before and after autologous stem cell transplantation. Remarkably, after cytokine stimulation, the patients' NK cells did not significantly differ from those of healthy donors. In a small cohort of MM patients…
Algebraic singularities have maximal reductive automorphism groups
1989
LetX = On/ibe an analytic singularity where ṫ is an ideal of theC-algebraOnof germs of analytic functions on (Cn, 0). Letdenote the maximal ideal ofXandA= AutXits group of automorphisms. An abstract subgroupequipped with the structure of an algebraic group is calledalgebraic subgroupofAif the natural representations ofGon all “higher cotangent spaces”are rational. Letπbe the representation ofAon the first cotangent spaceandA1=π(A).
Hepatocellular cancer cell lines, Hep-3B and Hep-G2 display the pleiotropic response to resveratrol and berberine
2022
Purpose Human carcinoma cells with different p53 status exposed to a combination of bioactive substances, resveratrol and berberine, revealed different responses in cell viability via p53-dependant apoptosis pathway activation. Materials and methods Using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, we investigated various and opposing effects in hepatocellular carcinoma cells, Hep-G2 and Hep-3B with different p53-status. Results Cells decreased in viability after treatment with dose-dependent concentrations of resveratrol and berberine. Hep-3B p53 mutants were more sensitive in comparison to the p53 wild type Hep-G2 cell line. A syne…
Targeting HSP90 with the small molecule inhibitor AUY922 (luminespib) as a treatment strategy against hepatocellular carcinoma
2018
Hepatocellular carcinoma (HCC) is a highly malignant tumor that responds very poorly to existing therapies, most probably due to its extraordinary inter- and intra-tumor molecular heterogeneity. The modest therapeutic response to molecular targeted agents underlines the need for new therapeutic approaches for HCC. In our study, we took advantage of well-characterized human HCC cell lines, differing in transcriptomic subtypes, DNA mutation and amplification alterations, reflecting the heterogeneity of primary HCCs, to provide a preclinical evaluation of the specific heat shock protein 90 (HSP90) inhibitor AUY922 (luminespib). Indeed, HSP90 is highly expressed in different tumor types, but it…